ZimVie (ZIMV) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

ZIMV Stock Forecast

ZimVie stock forecast is as follows: an average price target of $14.50 (represents a 5.53% upside from ZIMV’s last price of $13.74) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

ZIMV Price Target

The average price target for ZimVie (ZIMV) is $14.50 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $20.00 to $9.00. This represents a potential 5.53% upside from ZIMV's last price of $13.74.

ZIMV Analyst Ratings

Buy

According to 2 Wall Street analysts, ZimVie's rating consensus is 'Buy'. The analyst rating breakdown for ZIMV stock is 0 'Strong Buy' (0.00%), 1 'Buy' (50.00%), 0 'Hold' (0.00%), 1 'Sell' (50.00%), and 0 'Strong Sell' (0.00%).

ZimVie Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
May 16, 2024	David Saxon	Needham	$20.00	$16.68	19.90%	45.56%
Dec 21, 2022	-	Barclays	$9.00	$8.70	3.45%	-34.50%

Row per page

Go to

The latest ZimVie stock forecast, released on May 16, 2024 by David Saxon from Needham, set a price target of $20.00, which represents a 19.90% increase from the stock price at the time of the forecast ($16.68), and a 45.56% increase from ZIMV last price ($13.74).

ZimVie Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	1
Avg Price Target	-	-	$20.00
Last Closing Price	$13.74	$13.74	$13.74
Upside/Downside	-100.00%	-100.00%	45.56%

In the current month, the average price target of ZimVie stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to ZimVie's last price of $13.74. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Jun 25, 2024	Needham	Buy	Buy	Hold
May 16, 2024	Needham	-	Buy	Upgrade
Aug 08, 2023	Barclays	Underweight	Underweight	Hold
Dec 21, 2022	Barclays	-	Underweight	Initialise

Row per page

Go to

ZimVie's last stock rating was published by Needham on Jun 25, 2024. The company gave ZIMV a "Buy" rating, the same as its previous rate.

ZimVie Financial Forecast

ZimVie Revenue Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Revenue	-	-	-	-	-	-	-	-	-	$202.87M	$224.90M	$225.43M	$229.12M	$214.58M	$234.56M	$235.60M	$261.60M
Avg Forecast	$114.51M	$104.58M	$118.45M	$119.38M	$113.40M	$103.22M	$115.00M	$116.00M	$213.00M	$196.00M	$212.00M	$207.00M	$237.00M	$215.00M	$233.37M	$224.87M	$260.70M
High Forecast	$114.51M	$104.58M	$118.45M	$119.38M	$113.40M	$104.13M	$115.00M	$116.00M	$213.00M	$196.00M	$212.00M	$207.00M	$237.00M	$215.00M	$233.37M	$224.87M	$260.70M
Low Forecast	$114.51M	$104.58M	$118.45M	$119.38M	$113.40M	$102.31M	$115.00M	$116.00M	$213.00M	$196.00M	$212.00M	$207.00M	$237.00M	$215.00M	$233.37M	$224.87M	$260.70M
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Surprise %	-	-	-	-	-	-	-	-	-	1.04%	1.06%	1.09%	0.97%	1.00%	1.01%	1.05%	1.00%

ZimVie's average Quarter revenue forecast for Dec 23 based on 1 analysts is $213.00M, with a low forecast of $213.00M, and a high forecast of $213.00M. ZIMV's average Quarter revenue forecast represents a 4.99% increase compared to the company's last Quarter revenue of $202.87M (Sep 23).

ZimVie EBITDA Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
EBITDA	-	-	-	-	-	-	-	-	-	$57.88M	$61.37M	$22.26M	$7.75M	$22.56M	$22.06M	$9.93M	$-18.30M
Avg Forecast	$7.35M	$6.71M	$7.60M	$7.66M	$7.28M	$6.62M	$7.38M	$7.44M	$13.67M	$12.58M	$13.60M	$13.28M	$15.21M	$23.89M	$25.93M	$24.99M	$28.97M
High Forecast	$7.35M	$6.71M	$7.60M	$7.66M	$7.28M	$6.68M	$7.38M	$7.44M	$13.67M	$12.58M	$13.60M	$13.28M	$15.21M	$23.89M	$25.93M	$24.99M	$28.97M
Low Forecast	$7.35M	$6.71M	$7.60M	$7.66M	$7.28M	$6.56M	$7.38M	$7.44M	$13.67M	$12.58M	$13.60M	$13.28M	$15.21M	$23.89M	$25.93M	$24.99M	$28.97M
Surprise %	-	-	-	-	-	-	-	-	-	4.60%	4.51%	1.68%	0.51%	0.94%	0.85%	0.40%	-0.63%

1 analysts predict ZIMV's average Quarter EBITDA for Dec 23 to be $13.67M, with a high of $13.67M and a low of $13.67M. This is -76.39% lower than ZimVie's previous annual EBITDA (Sep 23) of $57.88M.

ZimVie Net Income Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Net Income	-	-	-	-	-	-	-	-	-	$-5.09M	$-23.37M	$-29.97M	$-30.34M	$831.00K	$-8.71M	$-25.66M	$-60.70M
Avg Forecast	$6.07M	$3.31M	$4.96M	$3.86M	$7.17M	$3.29M	$4.83M	$-1.10M	$3.45M	$-551.48K	$689.35K	$1.52M	$5.79M	$7.40M	$18.49M	$10.34M	$21.92M
High Forecast	$6.07M	$3.31M	$4.96M	$3.86M	$7.51M	$3.29M	$4.83M	$-1.10M	$3.45M	$-551.48K	$689.35K	$1.52M	$5.79M	$7.40M	$18.49M	$10.34M	$21.92M
Low Forecast	$6.07M	$3.31M	$4.96M	$3.86M	$6.83M	$3.29M	$4.83M	$-1.10M	$3.45M	$-551.48K	$689.35K	$1.52M	$5.79M	$7.40M	$18.49M	$10.34M	$21.92M
Surprise %	-	-	-	-	-	-	-	-	-	9.23%	-33.91%	-19.76%	-5.24%	0.11%	-0.47%	-2.48%	-2.77%

ZimVie's average Quarter net income forecast for Dec 22 is $5.79M, with a range of $5.79M to $5.79M. ZIMV's average Quarter net income forecast represents a 596.82% increase compared to the company's last Quarter net income of $831.00K (Sep 22).

ZimVie SG&A Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
SG&A	-	-	-	-	-	-	-	-	-	$117.35M	$128.48M	$127.97M	$134.46M	$129.34M	$126.05M	$134.11M	$149.30M
Avg Forecast	$64.64M	$59.03M	$66.86M	$67.38M	$64.01M	$58.27M	$64.91M	$65.48M	$120.23M	$110.64M	$119.67M	$116.84M	$133.78M	$121.36M	$131.73M	$126.93M	$147.16M
High Forecast	$64.64M	$59.03M	$66.86M	$67.38M	$64.01M	$58.78M	$64.91M	$65.48M	$120.23M	$110.64M	$119.67M	$116.84M	$133.78M	$121.36M	$131.73M	$126.93M	$147.16M
Low Forecast	$64.64M	$59.03M	$66.86M	$67.38M	$64.01M	$57.75M	$64.91M	$65.48M	$120.23M	$110.64M	$119.67M	$116.84M	$133.78M	$121.36M	$131.73M	$126.93M	$147.16M
Surprise %	-	-	-	-	-	-	-	-	-	1.06%	1.07%	1.10%	1.01%	1.07%	0.96%	1.06%	1.01%

ZimVie's average Quarter SG&A projection for Dec 23 is $120.23M, based on 1 Wall Street analysts, with a range of $120.23M to $120.23M. The forecast indicates a 2.45% rise compared to ZIMV last annual SG&A of $117.35M (Sep 23).

ZimVie EPS Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
EPS	-	-	-	-	-	-	-	-	-	$-0.19	$-0.89	$-1.14	$-1.16	$0.03	$-0.33	$-0.98	$-2.33
Avg Forecast	$0.22	$0.12	$0.18	$0.14	$0.26	$0.12	$0.17	$-0.04	$0.13	$-0.02	$0.03	$0.06	$0.21	$0.27	$0.67	$0.38	$0.80
High Forecast	$0.22	$0.12	$0.18	$0.14	$0.27	$0.12	$0.17	$-0.04	$0.13	$-0.02	$0.03	$0.06	$0.21	$0.27	$0.67	$0.38	$0.80
Low Forecast	$0.22	$0.12	$0.18	$0.14	$0.25	$0.12	$0.17	$-0.04	$0.13	$-0.02	$0.03	$0.06	$0.21	$0.27	$0.67	$0.38	$0.80
Surprise %	-	-	-	-	-	-	-	-	-	9.50%	-35.60%	-20.73%	-5.52%	0.11%	-0.49%	-2.60%	-2.91%

According to 1 Wall Street analysts, ZimVie's projected average Quarter EPS for Dec 22 is $0.21, with a low estimate of $0.21 and a high estimate of $0.21. This represents a 600.00% increase compared to ZIMV previous annual EPS of $0.03 (Sep 22).

ZimVie Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
APYX	Apyx Medical	$1.42	$8.50	498.59%	Buy
INGN	Inogen	$9.21	$26.00	182.30%	Buy
SGHT	Sight Sciences	$3.76	$9.00	139.36%	Hold
LUNG	Pulmonx	$6.42	$11.93	85.83%	Buy
SIBN	SI-BONE	$12.29	$20.00	62.73%	Buy
KIDS	OrthoPediatrics	$26.47	$39.60	49.60%	Buy
NPCE	NeuroPace	$9.00	$12.88	43.11%	Buy
CNMD	CONMED	$71.71	$96.00	33.87%	Buy
OFIX	Orthofix Medical	$18.68	$24.00	28.48%	-
STE	STERIS	$215.77	$256.67	18.96%	Buy
CVRX	CVRx	$14.77	$16.33	10.56%	Buy
AORT	Artivion	$28.03	$30.60	9.17%	Buy
SNN	Smith & Nephew	$25.04	$27.00	7.83%	Buy
ZIMV	ZimVie	$13.74	$14.50	5.53%	Buy
SRDX	Surmodics	$39.19	$39.50	0.79%	Buy
SYK	Stryker	$390.14	$317.96	-18.50%	Buy

ZIMV Forecast FAQ

Is ZimVie a good buy?

Yes, according to 2 Wall Street analysts, ZimVie (ZIMV) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 50.00% of ZIMV's total ratings.

What is ZIMV's price target?

ZimVie (ZIMV) average price target is $14.5 with a range of $9 to $20, implying a 5.53% from its last price of $13.74. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will ZimVie stock go up soon?

According to Wall Street analysts' prediction for ZIMV stock, the company can go up by 5.53% (from the last price of $13.74 to the average price target of $14.5), up by 45.56% based on the highest stock price target, and down by -34.50% based on the lowest stock price target.

Can ZimVie stock reach $20?

ZIMV's average twelve months analyst stock price target of $14.5 does not support the claim that ZimVie can reach $20 in the near future.

What are ZimVie's analysts' financial forecasts?

ZimVie's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $447.62M (high $448.53M, low $446.71M), average EBITDA is $28.72M (high $28.78M, low $28.66M), average net income is $14.19M (high $14.53M, low $13.84M), average SG&A $252.67M (high $253.18M, low $252.15M), and average EPS is $0.514 (high $0.527, low $0.502). ZIMV's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $456.92M (high $456.92M, low $456.92M), average EBITDA is $29.32M (high $29.32M, low $29.32M), average net income is $18.2M (high $18.2M, low $18.2M), average SG&A $257.92M (high $257.92M, low $257.92M), and average EPS is $0.66 (high $0.66, low $0.66).

Did the ZIMV's actual financial results beat the analysts' financial forecasts?

Based on ZimVie's last annual report (Dec 2022), the company's revenue was $913.86M, beating the average analysts forecast of $910.23M by 0.40%. Apple's EBITDA was $71.94M, missing the average prediction of $90.03M by -20.09%. The company's net income was $-63.881M, missing the average estimation of $42.02M by -252.03%. Apple's SG&A was $523.97M, beating the average forecast of $513.8M by 1.98%. Lastly, the company's EPS was $-2.45, missing the average prediction of $1.53 by -259.92%. In terms of the last quarterly report (Sep 2023), ZimVie's revenue was $202.87M, beating the average analysts' forecast of $196M by 3.51%. The company's EBITDA was $57.88M, beating the average prediction of $12.58M by 360.24%. ZimVie's net income was $-5.089M, beating the average estimation of $-551K by 822.79%. The company's SG&A was $117.35M, beating the average forecast of $110.64M by 6.07%. Lastly, the company's EPS was $-0.19, beating the average prediction of $-0.02 by 850.00%